Orion Partners with Shilpa Medicare for Albumin Supply Deal

Shilpa Biocare, an integral Shilpa Medicare subsidiary, has signed a commercial supply contract across Europe with Orion Corporation for its recombinant human albumin, ahead of the Bio International Bio Convention in Boston.

Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181

Merck, also known as MSD outside the U.S. and Canada, has initiated its Phase 3 clinical trial, MOBILIZE-1 (V181-005), to evaluate the safety, immunogenicity, and efficacy of its investigational dengue vaccine, V181.

NVIDIA and Novo Nordisk Join Forces to Accelerate AI-Driven Drug Discovery

NVIDIA has announced a strategic alliance with Novo Nordisk to accelerate drug discovery using the power of AI and supercomputing. The partnership with DCAI's Gefion AI supercomputer, which is...

Gujarat Boosts Drug Testing with Rs. 8 Cr Upgrade to Rajkot Lab

In a significant milestone in the enhancement of pharmaceutical quality control, the Gujarat Food and Drug Control Administration (FDCA) has now provided Rs. 8 crore to the Gujarat Medical Services Corporation Limited

FDA Approves Enflonsia to Prevent RSV in Infants with One Dose

Merck reported that the USFDA had approved enflosina (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV)-induced lower respiratory tract illness in newborns and babies beginning their first RSV season.

Bharat Biotech Partners with GSK for Shigella Vaccine Development

Bharat Biotech International Limited (BBIL) announces a strategic partnership with GSK plc to advance the development and distribution of the Shigella vaccine candidate, altSonflex1-2-3. Shigellosis, a serious bacterial...

IPA Flags Concern Over MR Ban in Govt Hospitals

The Indian Pharmaceutical Alliance (IPA) represents major domestic drug companies has expressed concern over a recent directive from the government which bans medical representatives from visiting

Apisolex Excipient by Lubrizol Backs Phase I Drug Success

A promising drug candidate using Lubrizol Life Science Health's new polymer excipient Apisolex has begun Phase I clinical trials. This marks a big step forward for the technology that boosts solubility.

Brenntag Acquires mcePharma to Boost Pharma Services in EMEA

Brenntag, the leading distributor of chemicals and additives worldwide, announced that it has acquired mcePharma in the Czech Republic. Brenntag's capabilities throughout the whole pharmaceutical

Biocon Foundation Launches BioWISE Program to Empower Women in STEM

Biocon Foundation, the CSR arm of Biocon Group, has launched BioWISE – Women in STEM Empowered – a pioneering initiative to support women science students from underrepresented communities in Karnataka. In collaboration with The Bengaluru Scien...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.